Immediate Impact
59 standout
Citing Papers
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Pyridinium Rotor Strategy toward a Robust Photothermal Agent for STING Activation and Multimodal Image-Guided Immunotherapy for Triple-Negative Breast Cancer
2025 Standout
Works of Nianhua Ding being referenced
Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nianhua Ding | 218 | 197 | 53 | 127 | 17 | 544 | |
| Xiaofang Zhao | 211 | 181 | 15 | 100 | 26 | 512 | |
| Xiangyuan Luo | 145 | 351 | 34 | 116 | 19 | 627 | |
| Kaja C. G. Berg | 321 | 297 | 36 | 67 | 17 | 646 | |
| Beibei Zhai | 193 | 273 | 34 | 34 | 23 | 505 | |
| Liqin Yuan | 163 | 259 | 10 | 76 | 29 | 624 | |
| Jin‐Qiu Chen | 280 | 308 | 34 | 129 | 17 | 594 | |
| G. Guetens | 284 | 258 | 15 | 32 | 23 | 641 | |
| M. J. Duffy | 266 | 274 | 26 | 56 | 22 | 638 | |
| Christopher Toth | 205 | 227 | 18 | 130 | 15 | 576 | |
| Shushan Rana | 170 | 292 | 51 | 44 | 17 | 590 |
All Works
Login with ORCID to disown or claim papers
Loading papers...